๐ฐ Biochemical Sciences News
Page 3 - Biochemical Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biochemical Sciences. Real-time updates on events, politics, business and more.
May 26, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced a series of actions as part of its ongoing commitment to strong corporate governance and regular...
May 26, 2022
- Appoints Nancy J. Wysenski as New Lead Independent Director - - David W. Anstice AO and Wendy L. Dixon, Ph.D. to Retire From Board - - Files Preliminary Proxy Statement and Highlights
May 26, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced a series of actions as part of its ongoing commitment to strong corporate governance and regular...
May 13, 2022
Conference call scheduled for 8:30 a.m. ET today...
May 13, 2022
13.05.2022 - Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) - Longeveron Inc. (NASDAQ: LGVN) (Longeveron or Company), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and ...
May 6, 2022
Spotlight on Dr. Susan Parkhurst. Dr. Parkhurst studies the cytoskeleton, the cellโs internal framework.
May 4, 2022
YEREVAN, MAY 4, ARMENPRESS. Karen Trchunyan, Deputy Minister of Education, Science, Culture and Sports of the Republic of Armenia, is a promising young scientist, Doctor of Biological Sciences, and professor. He is an author and co-author of over 50 articles published in international science and technology repositories. The number of references to his studies is approximately 1300, H-index fluctuates within the range of 21-23, depending on the repository - Google Scholar, Web of Sciences, Scopu...
May 2, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
February 23, 2022
Oceanside, NY, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Mount Sinai South Nassau, an award-winning not-for-profit teaching hospital, has appointed George...
January 5, 2022
BERKELEY, CA / ACCESSWIRE / January 5, 2022 / Chameleon Biosciences Inc., a company developing the EVADERTM platform to produce next-generation gene therapies that are more potent and less immunogenic